Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 36 Issue 6
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2018  >  36(6): 484-487,498

MENG Gefei, CHAI Rongrong, DING Jianing, ZHU Congcong, ZHU Quangang. Research progress on matrix formulations of Traditional Chinese Medicine cataplasm[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(6): 484-487,498. doi: 10.3969/j.issn.1006-0111.2018.06.002
Citation: MENG Gefei, CHAI Rongrong, DING Jianing, ZHU Congcong, ZHU Quangang. Research progress on matrix formulations of Traditional Chinese Medicine cataplasm[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(6): 484-487,498. doi: 10.3969/j.issn.1006-0111.2018.06.002
shu

Research progress on matrix formulations of Traditional Chinese Medicine cataplasm

doi: 10.3969/j.issn.1006-0111.2018.06.002
  • 1.

    Department of Pharmacy, Yueyang Integrated Chinese and Western Medicine Hospital affiliated to Shanghai University of TCM, Shanghai 200437, China

  • 2.

    Department of Pharmacy, Yueyang Integrated Chinese and Western Medicine Hospital affiliated to Shanghai University of TCM, Shanghai 200437, China;Department of Pharmacy, Shanghai Dermatology Hospital, Shanghai 200443, China

  • Received Date: 2018-07-13
  • Rev Recd Date: 2018-09-03
  • Traditional Chinese Medicine cataplasm has remarkable clinical effects with the advantages of no liver first-pass and easy to apply. It is one of the most promising drug delivery systems following oral and injective administration. In this paper, the matrix components used in the cataplasm and their functions were reviewed. The matrix formulations include skeleton material, thickener, moisturizing agent, crosslinking agent, crosslinking regulator, filler, transdermal promoting agent and other additives. Their definition, functions, varieties, physical and chemical properties, research status and the methods of matrix design were summarized. The challenges and prospective developments in matrix formulations were also discussed.
  • [1] 刘旭.敷贴疗法内病外治的应用及进展[J].中外医疗,2011,30(1):125-126.
    [2] 刘晓,王富昌.对中医内病外治的思考与展望[J].西部医学,2007,19(2):239-240.
    [3] 张成桂,何苗,巫秀美,等.国内凝胶膏剂的专利分析[J].大理学院学报,2012,11(9):11-15.
    [4] 黄丽,余冰欣,袁雪,等.亲水性凝胶膏剂的研究进展[J].中国民族民间医药,2016,25(19):102-104.
    [5] 韩飞,王琳,陈荣明,等.中药凝胶膏剂的研究进展[J].江西中医药,2014,45(5):78-80.
    [6] 傅静娟,刘志辉,罗会盛,等.凝胶膏剂的研究进展[J].中国民族民间医药杂志,2011,20(13):12-13.
    [7] 张华.那如-3巴布剂的毒理及其相对生物利用度研究[D].北京:北京中医药大学,2007.
    [8] 李文逸,杜松云,杨艾玲,等.咳喘灵凝胶膏剂基质配比研究[J].山东化工,2017,46(2):5-6+8.
    [9] 杨华生,陈丽华,黎晓丽,等.基于新型交联剂Eudragit RS100的凝胶贴膏基质考察[J].中国医药工业杂志,2015,46(12):1311-1316.
    [10] 刘楠楠,郭淑云,王庆伟,等.香附挥发油透皮特性及对对乙酰氨基酚的促透皮作用[J].医药导报,2013,32(9):1127-1130.
    [11] 单玲玲,靳光乾,王平,等.中药透皮吸收促进剂研究[J].辽宁中医药大学学报,2013,15(5):112-114.
    [12] 宋立华,刘淑芝.中药凝胶膏剂的研究进展分析[J].中国实验方剂学杂志,2015,21(22):133-136.
    [13] 周艳,黄志辉,区展龙,等.跌打祛风膏基质处方的优化研究[J].中药材,2016,39(4):846-849.
    [14] 邓启焕,秦劬学.水溶性高分子基质中药贴膏的研制[J].中草药,2000,31(5):32-34.
    [15] 朱力阳,马建,涂禾,等.丁桂凝胶基质的配方优化筛选[J].中国医院药学杂志,2013,33(12):931-933.
    [16] 江苏康倍得药业有限公司.亲水性组合物及含有该组合物的巴布剂:CN103893775A[P].2014-07-02.
    [17] 高苑,薛晶,刘芳,等.鱼腥草挥发油-尼古丁水凝胶膏剂基质配方的优化[J].中成药,2018,40(1):222-224.
    [18] 侯雪梅,丁宝月,张纬,等.水凝胶贴剂的研究进展及目前存在的问题[J].药学服务与研究,2012,12(6):442-446.
    [19] 区展龙,罗秀英,严春霞,等.中药止痛贴膏(清热型)含药量与基质相容性的研究[J].北方药学,2017,14(10):140-141+169.
    [20] WANG J, ZHANG H, AN D, et al. Rheological characterization of cataplasm bases composed of cross-linked partially neutralized polyacrylate hydrogel[J]. AAPS Pharm Sci Tech, 2014, 15(5):1149-1154.
    [21] 李伟泽,张光伟,赵宁,等.中药水凝胶巴布剂产业化工艺技术攻关研究[J].中草药,2012,10:1928-1933.
    [22] 呼永河,刘爱琴,李静,等.中药巴布剂的基质研究进展[J].医学综述,2012,18(13):2093-2096.
    [23] RIVIERE JE, BROOKS JD. Predicting skin permeability from complex chemical mixtures:dependency of quantitative structure permeation relationships on biology of skin model used[J]. Toxicol Sci, 2011, 119(1):224-232.
    [24] 黄雨威,王利胜,兰小群,等.促渗剂对消喘巴布剂中白芥子体外透皮吸收特性的影响[J].中国医院药学杂志,2013,33(21):1754-1757.
    [25] 董礼,徐希明,余江南.中药凝胶膏剂研究概述[J].中国药师,2011,14(1):129-132.
    [26] 杨全伟,程璐,马浩然,等.星点设计-效应面法(CCD-RSM)优选颈痛巴布剂提取工艺研究[J].云南中医学院学报,2015,38(6):28-31+50.
    [27] 徐如冰,马政瑶,贾永艳.星点设计优选归红活血凝胶膏剂基质处方[J].世界中医药,2017,12(10):2462-2465.
    [28] 宋立华,杜茂波,刘淑芝,等.Plackett-Burman联用Box-Behnken响应面法优化凝胶膏剂基质研究[J].中成药,2015,37(12):2623-2627.
    [29] 黄诗莹,张丽娟,柯龙华,等.Box-Behnken响应面法优选豨桐凝胶贴膏的提取工艺[J].广东药科大学学报,2017,33(01):37-42.
    [30] 章烨雯,于竞新,王景雁,等.D-最优混料设计结合多种力学指标优化柴栀凝胶贴膏的基质处方及其体外释放透皮研究[J].中国中药杂志,2016,41(6):1046-1053.
    [31] 王璐璐,刘炳周,王满,等.主成分分析结合均匀设计法用于优选桂芍巴布贴制备工艺的研究[J].中草药,2016,47(10):1682-1689.
    [32] 王森,欧水平,袁涛.均匀设计法结合动态优化法优选复方独一味凝胶贴膏的提取工艺[J].中国药房,2016,27(31):4439-4442.
    [33] 吴璐,吴维刚,江亭,等.制川乌凝胶膏剂基质处方优化及体外释放研究[J].中国药房,2018,29(1):37-41.
    [34] 王奕博,杜梓萱,黄特辉,等.中药凝胶贴膏基质选择及挥发油加入方式研究进展[J].中草药,2018,49(11):2715-2721.
    [35] 刘惠娟,邹传宗.白花菜巴布剂的制备与其抗炎镇痛活性研究[J].中国新药杂志,2018,27(1):97-101.
    [36] 郭慧玲,骆云霞,胡律江,等.基于流变学特性的凝胶贴膏剂基质处方筛选研究[J].江西中医药大学学报,2016,28(6):81-85+108.
    [37] 顾圣莹,张玮,张丽娟,等.巴布剂的黏性评价研究进展[J].实用药物与临床,2017,20(12):1441-1444.
    [38] 杨华生,黎晓丽,吴璐,等.中药凝胶贴膏质量研究进展与思考[J].中医外治杂志,2016,25(3):3-5.
    [39] 潘林梅,郭立玮,袁铸人,等.中药巴布剂产业化问题探讨[J].中国药房,2007,18(30):2394-2396.
    [40] 李伟泽,赵宁,师湘月,等.胶束增溶技术在含挥发油中药巴布剂试生产中的应用研究[J].中草药,2013,44(19):2677-2682.
    [41] 彭伟文,王珠强,吴飞.相关药物巴布剂的药效学及毒理学研究近况[J].中国药房,2016,27(19):2711-2714.
  • 加载中
通讯作者: 陈斌, [email protected]
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(4125) PDF downloads(507) Cited by()

Related
Proportional views

Research progress on matrix formulations of Traditional Chinese Medicine cataplasm

doi: 10.3969/j.issn.1006-0111.2018.06.002
  • 1. Department of Pharmacy, Yueyang Integrated Chinese and Western Medicine Hospital affiliated to Shanghai University of TCM, Shanghai 200437, China
  • 2. Department of Pharmacy, Yueyang Integrated Chinese and Western Medicine Hospital affiliated to Shanghai University of TCM, Shanghai 200437, China;Department of Pharmacy, Shanghai Dermatology Hospital, Shanghai 200443, China
  • Received Date: 2018-07-13
  • Rev Recd Date: 2018-09-03

Abstract: Traditional Chinese Medicine cataplasm has remarkable clinical effects with the advantages of no liver first-pass and easy to apply. It is one of the most promising drug delivery systems following oral and injective administration. In this paper, the matrix components used in the cataplasm and their functions were reviewed. The matrix formulations include skeleton material, thickener, moisturizing agent, crosslinking agent, crosslinking regulator, filler, transdermal promoting agent and other additives. Their definition, functions, varieties, physical and chemical properties, research status and the methods of matrix design were summarized. The challenges and prospective developments in matrix formulations were also discussed.

MENG Gefei, CHAI Rongrong, DING Jianing, ZHU Congcong, ZHU Quangang. Research progress on matrix formulations of Traditional Chinese Medicine cataplasm[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(6): 484-487,498. doi: 10.3969/j.issn.1006-0111.2018.06.002
Citation: MENG Gefei, CHAI Rongrong, DING Jianing, ZHU Congcong, ZHU Quangang. Research progress on matrix formulations of Traditional Chinese Medicine cataplasm[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(6): 484-487,498. doi: 10.3969/j.issn.1006-0111.2018.06.002
shu

    HTML

Reference (41)

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: [email protected]

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return